These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9818612)

  • 21. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
    Keltner JL; Johnson CA; Anderson DR; Levine RA; Fan J; Cello KE; Quigley HA; Budenz DL; Parrish RK; Kass MA; Gordon MO;
    Ophthalmology; 2006 Sep; 113(9):1603-12. PubMed ID: 16949445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma.
    Juzych MS; Chopra V; Banitt MR; Hughes BA; Kim C; Goulas MT; Shin DH
    Ophthalmology; 2004 Oct; 111(10):1853-9. PubMed ID: 15465546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota.
    Malihi M; Moura Filho ER; Hodge DO; Sit AJ
    Ophthalmology; 2014 Jan; 121(1):134-141. PubMed ID: 24823760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma.
    Law SK; Shih K; Tran DH; Coleman AL; Caprioli J
    Am J Ophthalmol; 2009 Nov; 148(5):685-695.e1. PubMed ID: 19596220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothyroidism and the risk of developing open-angle glaucoma: a five-year population-based follow-up study.
    Lin HC; Kang JH; Jiang YD; Ho JD
    Ophthalmology; 2010 Oct; 117(10):1960-6. PubMed ID: 20557938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki Eye Study.
    Topouzis F; Coleman AL; Harris A; Koskosas A; Founti P; Gong G; Yu F; Anastasopoulos E; Pappas T; Wilson MR
    Am J Ophthalmol; 2008 Feb; 145(2):327-335. PubMed ID: 18045565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study.
    Iwase A; Suzuki Y; Araie M; Yamamoto T; Abe H; Shirato S; Kuwayama Y; Mishima HK; Shimizu H; Tomita G; Inoue Y; Kitazawa Y;
    Ophthalmology; 2004 Sep; 111(9):1641-8. PubMed ID: 15350316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular pressure as a risk factor for visual field loss in pseudoexfoliative and in primary open-angle glaucoma.
    Teus MA; Castejón MA; Calvo MA; Pérez-Salaíces P; Marcos A
    Ophthalmology; 1998 Dec; 105(12):2225-9; discussion 2229-30. PubMed ID: 9855151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of open-angle glaucoma in central Sweden.
    Ekström C
    Acta Ophthalmol; 2008 Nov; 86(7):747-54. PubMed ID: 18785965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a learning effect in short-wavelength automated perimetry.
    Wild JM; Kim LS; Pacey IE; Cunliffe IA
    Ophthalmology; 2006 Feb; 113(2):206-15. PubMed ID: 16458091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lifetime risk of blindness in open-angle glaucoma.
    Peters D; Bengtsson B; Heijl A
    Am J Ophthalmol; 2013 Oct; 156(4):724-30. PubMed ID: 23932216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trabeculotomy combined with phacoemulsification and implantation of intraocular lens for primary open-angle glaucoma.
    Mizoguchi T; Kuroda S; Terauchi H; Nagata M
    Semin Ophthalmol; 2001 Sep; 16(3):162-7. PubMed ID: 15513436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of the European Glaucoma Prevention Study.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Social Vulnerability Index on the Development of Severe Visual Impairment or Blindness From Glaucoma.
    Swaminathan SS; Medeiros FA; Gedde SJ
    Am J Ophthalmol; 2024 Nov; 267():172-181. PubMed ID: 38971319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.